1. Market Research
  2. > Pharmaceutical Market Trends

Indonesia Pharmaceuticals & Health Care Industry Report - H2, 2013

  • April 2014
  • 31 pages
  • Emerging Markets Direct Media Holdings
Report ID: 3307070


Table of Contents

This report profiles the pharmaceutical and health care industry in Indonesia, with analysis of market trends through H2 2013 and market outlook through end-2020. The report also surveys the key firms in the sector, among them Kalbe, TSP, and Kimia.

Indonesia's pharmaceutical and health care sector has recorded double-digit growth over the last few years. However, in value terms, the domestic pharmaceutical industry was minuscule in size compared to markets like the USA and Japan. Low per capita income, the lower cost of drugs, and lower penetration and accessibility of health care were the main reasons for this low figure. Hence, immense potential exists for growth in Indonesia's pharmaceutical sector. However, the sector is often plagued by regulatory flip-flops, drug approval delays, currency fluctuations, unethical practices and pricing controls.

The pharmaceutical market saw a challenging period in 2013, with growth of only 9% after growing by 15% in 2012. Lower economic growth and higher inflation led to this subdued performance. Depreciation of the IDR, higher electricity tariffs, and higher minimum wages also led to erosion in the profit margins of pharmaceutical manufacturers during 2013. However, the implementation of National Health Insurance (JKN) program by the Social Security Agency (BPJS) in 2014 is expected to significantly boost sales of drugs, particularly generic drugs. According to the Association of Pharmaceutical Entrepreneurs (GP Farmasi), the size of the pharmaceutical market is expected to record a y/y growth of 13% in 2014. Such revenue growth will also offset the recent decline in profit margins. Both domestic as well as foreign companies are gearing up and expanding their production capacities to meet the expected demand growth after the implementation of JKN.

Going forward, the market is expected to return to a double-digit growth track, thanks to government support and various macro growth drivers including the rise in per capita income, the rise in health insurance penetration, the proliferation of health care services across the remote areas, the rise in lifestyle diseases, and the increase in foreign investments and in government as well as private expenditure on health. However, frequent policy changes and rising prices of raw materials may act as deterrents of growth for this sector.

Key Points:

o This report outlines the market position and financial information for leading sectoral players, including PT Kalbe Farma Tbk (Kalbe), PT Tempo Scan Pacific Tbk (TSPC), and PT Kimia Farma (Persero) Tbk (Kimia).

o The government sector accounted for around 34% of total health care spending and the private sector for the remainder. The health care industry saw a CAGR of around 20% during the period 2006-11 and is expected to surpass USD 30bn by 2015.

o The government aims to have every Indonesian covered by health insurance before 2019 under the new scheme known as Jaminan Kesehatan Nasional (JKN), with nearly IDR 20tn (US$1.6 billion) allocated to cover premiums for the poor in 2014. The scheme was launched on December 31, 2013, by President Susilo Bambang Yudhoyono.

o Despite ongoing improvements in its infrastructure, the health care system is still struggling with the shortage of medical professionals in all segments of the health care system. As of 2012, a single physician served 4,900 citizens in the country. The government of Indonesia has targeted to bring down this figure to 2,500 at the end of its universal health coverage program.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...

Pharmaceutical Hot Melt Extrusion Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • February 2017
  • by Transparency Market Research

Global Pharmaceutical Hot Melt Extrusion Market: Overview This report provides forecast and analysis of the pharmaceutical hot melt extrusion market on the global and regional levels. It provides historical ...

Pulmonary/ Respiratory Drug Delivery Market by Formulation, Device Type, Canister, End User, Applications - Forecasts to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global pulmonary drug delivery market is projected to reach USD 52.37 billion by 2021 from USD 36.10 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing preference of pulmonary ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.